Showing results (61-70 of 79) with videos related to
Sort By:
Pageof 8
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Brofaromine--a review of its pharmacological properties and therapeutic useH P Volz, C H Gleiter, P C Waldmeier, et al.Biochemical Pharmacology|March 8, 1996
Determination of rat brain and plasma levels of the orally active GABAB antagonist 3-amino-propyl-n-butyl-phosphinic acid (CGP 36742) by a new GC/MS methodA F Steulet, H J Mobius, S J Mickel, et al.Neuroscience|August 1, 1983
Alteration of central alpha 2- and beta-adrenergic receptors in the rat after DSP-4, a selective noradrenergic neurotoxinD J Dooley, H Bittiger, K L Hauser, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 26, 2007
NIM811, a mitochondrial permeability transition inhibitor, prevents mitochondrial depolarization in small-for-size rat liver graftsZ Zhong, T P Theruvath, R T Currin, et al.Neurology|October 1, 1995
Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmittersP C Waldmeier, P A Baumann, P Wicki, et al.Journal of Neural Transmission. Supplementum|February 24, 2001
Neurorescuing effects of the GAPDH ligand CGP 3466BP C Waldmeier, A A Boulton, A R Cools, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1995
Effects of the putative P-type calcium channel blocker, R,R-(-)-daurisoline on neurotransmitter releaseP C Waldmeier, P Wicki, W Fröstl, et al.European Journal of Pharmacology|October 14, 1986
Ifoxetine, a compound with atypical effects on serotonin uptakeP C Waldmeier, L Maître, P A Baumann, et al.British Journal of Pharmacology|December 1, 1994
GABA and glutamate release affected by GABAB receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptorsP C Waldmeier, P Wicki, J J Feldtrauer, et al.European Journal of Pharmacology|December 15, 1984
CGP 4718 A, a new potential antidepressant with a dual mode of actionP C Waldmeier, K F Tipton, R Bernasconi, et al.Pageof 8